|
Development of a companion diagnostic assay for tissue hyaluronan detection and treatment with PEGPH20 in metastatic pancreatic ductal adenocarcinoma patients. |
|
|
Employment - Ventana Medical Systems |
Honoraria - Ventana Medical Systems |
|
|
Employment - Ventana Medical Systems |
|
|
No Relationships to Disclose |
|
|
Employment - Ventana Medical Systems |
|
|
Employment - Ventana Medical Systems |
|
|
Employment - Ventana Medical Systems |
|
|
Employment - Ventana Medical Systems |
|
|
Employment - Ventana Medical Systems |
|
|
|
|
|
|
Stock and Other Ownership Interests - Exelixis; Halozyme |
Consulting or Advisory Role - Anacor; Bayer; Mitomics; Zenith Epigenetics |
|
|
|
Stock and Other Ownership Interests - Halozyme |